Litigation Details for Par Pharmaceutical, Inc. v. Twi Pharmaceuticals, Inc. (Fed. Cir. 2014)
✉ Email this page to a colleague
Par Pharmaceutical, Inc. v. Twi Pharmaceuticals, Inc. (Fed. Cir. 2014)
| Docket | ⤷ Try a Trial | Date Filed | 2014-04-01 |
| Court | Court of Appeals for the Federal Circuit | Date Terminated | |
| Cause | Assigned To | ||
| Jury Demand | Referred To | ||
| Patents | 6,375,986; 7,101,576; 9,000,021 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Par Pharmaceutical, Inc. v. Twi Pharmaceuticals, Inc.
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for Par Pharmaceutical, Inc. v. Twi Pharmaceuticals, Inc. (Fed. Cir. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2014-06-02 | 46 | 1996; 10:1657-1662. 6,375,986 B1 4/2002 Ryde eta!. … Pat. No. Pat. No. 6,028,065. 6,375,986 for "Solid Dose Nanoparticulate Compositions… Liversidge ’363 patent (1995) and EP ’215 patent (1994). The ’363 patent, A14876-86, is a continuation…alleging infringement of U.S. Patent 7,101,576 (“the ‘576 patent”). The patent relates to Par’s Megace ES…the claims of the ‘576 patent are enabled, or whether the patent claims patentable subject matter. | External link to document | |
| 2014-08-19 | 65 | Motion Filed | the district court found that U.S. Patent 7,101,576 (the “’576 patent”) is invalid, ending over two years… ’576 patent were invalid as obvious. The entry of the final judgment rendered the ’576 patent invalid… its patent be held valid, Teva will be able to recover damages from respondents for past patent infringement…..................... 10, 13 In re Fenofibrate Patent Litigation, 972 F. Supp. 2d 655 (S.D.N.Y…brought suit against TWi for infringement of one patent under the Hatch-Waxman Act. A five-day trial was | External link to document |
| 2014-08-25 | 77 | that the asserted claims of U.S. Patent No. 7,101,576 (“’576 patent”) would have been obvious. Par filed…..........................13 In re Fenofibrate Patent Litigation, 972 F. Supp. 2d 655 (S.D.N.Y…Court’s analysis of the likelihood of success in a patent appeal. See Revision Military, Inc. v. Balboa Mfg…success for certain injunctions when applied to a patent case). This Court has expressly adopted Hilton’… instead relies (at 15-16) on In re Fenofibrate Patent Litigation, 972 F. Supp. 2d 655, 657 (S.D.N.Y. | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
